Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma
Authors:
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 99, 921-930
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 29 references indexed in Scilit:
- Gambogic Acid Sensitizes Ovarian Cancer Cells to Doxorubicin Through ROS-Mediated ApoptosisCell Biochemistry and Biophysics, 2013
- Enhancement of Carboplatin- and Quercetin-Induced Cell Death by Roscovitine Is Akt Dependent and p53 Independent in Hepatoma CellsIntegrative Cancer Therapies, 2011
- Severity of doxorubicin‐induced small intestinal mucositis is regulated by the TLR‐2 and TLR‐9 pathwaysThe Journal of Pathology, 2011
- Doxorubicin CardiomyopathyCardiology, 2009
- The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biologyJournal of Gastroenterology, 2009
- Molecular targeted therapy for hepatocellular carcinomaJournal of Gastroenterology, 2009
- Eritema acral inducido por quimioterapiaActas Dermo-Sifiliograficas, 2008
- Diagnosis and Treatment of Hepatocellular CarcinomaGastroenterology, 2008
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Integration of Chinese medicine into supportive cancer care:A modern role for an ancient traditionCancer Treatment Reviews, 2001